Skip links and keyboard navigation

About the QoVAX Program

The QoVAX Program will investigate factors that affect vaccine responses and how this relates to protection from naturally acquired COVID-19 infection and COVID-19 health outcomes over time.

Who can participate?

The QoVAX Program studies are open to Queensland residents aged 18 years and over. To ensure we represent the rich diversity of the Queensland population, we welcome all people who are eligible to participate including community members from the Aboriginal or Torres Strait Islander or South Sea Islander Nations, and adults from culturally and linguistically diverse (CALD) communities to take part.

Study eligibility

There are several research studies you can join depending on your vaccination status.

Statewide Study

  • you have had a COVID-19 vaccine in the last 12 months, or
  • you have not had any COVID-19 vaccine.

Pilot Booster Study

Received at least 2 doses of the COVID-19 vaccine and are about to get a booster dose.

Participant benefits

Participants are not paid to take part in any of the QoVAX Program studies and it will not affect the healthcare you receive.

Being involved means you are helping us to better understand the impacts of, and responses to, the COVID-19 vaccines and health impacts now and in the future.

Participant collection centres

You will need to go to a participating pathology collection centre to give blood and saliva samples (if applicable). To find out where you can have these specimens collected go to the individual study pages. If you are not sure, please contact the QoVAX Program team.

Medical conditions

There are no specific medical exclusions for these studies. If you have any specific health conditions, it might be best to talk to your doctor or treating health practitioner before taking part. If you think you’re unable to give blood due to a medical condition, please contact the QoVAX Program team.

If you have previously had or currently have COVID-19, you can participate in the studies. However, you should not attend a pathology collection centre to give a saliva (spit) or blood specimen until you have completed your mandatory isolation period and you are free of all symptoms.

Biological samples and the Biobank

All biological samples collected as part of the QoVAX Program will be saved in a biobank. A biobank is a repository (like a vault) that stores biological samples, such as blood, for use in clinical research.

Access to the biobank will be strictly controlled. Your samples and result information, including your survey responses and linked health information, will be stored de-identified to protect your privacy.

Your saliva and blood samples will be processed and stored in a linked digital data warehouse. A data interface will allow researchers to access samples to understand other aspects of the pandemic and, support COVID-19 vaccine related research in the future.

You can withdraw at any time. We will ask you to complete a withdrawal form so we know how you would like any remaining samples or data about you, that we have collected, to be managed.

First Nations and South Sea Islander Nations

The QoVAX Program will be guided by the QoVAX Program First Nations Steering Committee. This committee will be made-up of stakeholders and champions from health services who will review the safekeeping and knowledge given to us by our Aboriginal or Torres Strait or South Sea Islander participants.

Individual results

You will not receive, or be able to request, an analysis of your individual data because these are research tests and this study is helping us learn what they mean.

Combined data, showing an overview of participant information and responses, will be made available on the QoVAX Program website. In all instances, information will be provided in such a way that you cannot be identified.

Risks of participation

The purpose of the QoVAX Program is to see how the immune system responds to the COVID-19 vaccines, so there is minimal risk to your health and safety.

There will be no significant risk to you when you give a blood sample, as the amount of blood taken is small. A pathology staff member will take your blood sample, just like a routine blood test. In some rare cases, minor bruising, bleeding, and pain can occur at the site of injection.

In rare cases, immune function or genetic analysis results could affect your health or your families’ health. If this is the case, you will be contacted by a nominated clinical physician.

You might then be required to disclose this information to third parties i.e. insurance companies or employers. If you have any concerns, contact the QoVAX Program team.

More information about COVID-19 and the COVID-19 vaccines

These websites contain useful information about COVID-19 and the COVID-19 vaccines:

The QoVAX Program is not responsible for the COVID-19 vaccine immunisation program and these links are included as a courtesy to health consumers.

Last updated: 27 June 2022